The board of directors of Piramal Enterprises Limited has recommended a dividend of INR 17.5 per equity share (875%) for fiscal year 2013. The company reported unaudited consolidated and standalone earnings results for the fourth quarter and full year ended March 31, 2013. For the quarter, on consolidated basis, the company’s total operating income grew by 36.4% to INR 93,860 million against INR 68,810 million a year ago. Operating profit (OPBITDA) was INR 957 million compared to INR 780 million during the same period last year. Net loss was 20,040 million compared with net loss of INR 387 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 11.6 million compared to INR 2.3 for the same period a year ago. Loss from ordinary activities before tax was INR 1,909.7 million compared to INR 484.0 million for the same period a year ago. For the full year, on consolidated basis, the total operating income was up by 50.7% to INR 35,443 million as compared with 2012. Operating profit was INR 4,559 million against INR 1,925 million in the previous financial year. Net loss was INR 2,273 million compared with net profit of INR 1,115 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 13.2 million compared to basic and diluted earnings per share before and after extraordinary items of INR 6.6 for the same period a year ago. Loss from ordinary activities before tax was INR 1,927.2 million compared to income from ordinary activities before tax of INR 1,208.9 million for the same period a year ago. For the quarter, on standalone basis, the company reported net sales/income from operations of INR 3,688.2 million compared to INR 2,902.3 million for the same period a year ago. Profit from operations before other income, finance costs and exceptional items was INR 145.8 million compared to INR 80.5 million for the same period a year ago. Loss from ordinary activities before tax was INR 1,596.8 million compared to INR 772.7 million for the same period a year ago. Net loss was INR 1,521.7 million compared to INR 594.3 million for the same period a year ago. Basic and diluted loss per share before and after extraordinary items was INR 8.8 million compared to INR 3.5 for the same period a year ago. For the full year, on standalone basis, the company reported net sales/income from operations of INR 13,803.7 million compared to INR 10,962.5 million for the same period a year ago. Profit from operations before other income, finance costs and exceptional items was INR 128.5 million compared to INR 413.9 million for the same period a year ago. Loss from ordinary activities before tax was INR 2,478.8 million compared to profit from ordinary activities before tax INR 1,212.2 million for the same period a year ago. Net loss was INR 2,315.6 million compared to net income of INR 1,307.2 million for the same period a year ago. Basic and diluted loss per share before and after extraordinary items was INR 13.4 million compared to basic and diluted earnings per share before and after extraordinary items INR 7.7 for the same period a year ago.

Piramal Enterprises Limited, Board Meeting, May 03, 2013. Agenda: To consider and approve the audited financial results (consolidated and standalone) of the company for the financial year ended March 31, 2013 and also consider recommendation of dividend on the equity shares of the company for the financial year ended March 31, 2013.

Piramal Enterprises Limited announced the launch of its all new anti-aging cream ‘Lacto Calamine RENEU, with globally patented ULMAe technology, under its OTC segment. Lacto Calamine, known for a range of Skin Care products from Face lotion, Face wash to Sunscreen, is now introducing to Indian market an anti-ageing cream with US patented ULMAe delivery system having RENEU [ACTION]3 FORMULA. This RENEU [ACTION]3 FORMULA is a combination of three ingredients: Ultra Low Molecular Aminoglycan Extract (ULMAe); Nine Natural Nourishing Organic Extracts; and Natural Anti Melanin (NAM). ULMAe helps maintain skin’s elasticity and firmness, the 9 Natural Nourishing Organic Extracts hydrate the skin leaving it soft and smooth and the Natural Anti- Melanin (NAM) helps significantly to reduce skin pigmentation.